28 results
8-K
EX-3.3
KANT
Kineta, Inc.
22 Dec 22
Kineta Completes Reverse Merger with Yumanity Therapeutics
5:02pm
of the independence, or lack thereof, of such proposed nominee.
(8) Any written notice, supplement, update or other information required to be delivered
425
xm0twmyyhl3 09
6 Jun 22
Business combination disclosure
4:05pm
8-K
EX-2.2
qikl6fu hn770g8b
6 Jun 22
Yumanity Therapeutics Announces Definitive Agreements for Two Strategic Transactions
4:02pm
8-K
EX-1.1
xkdu jarm7
8 Apr 21
Entry into a Material Definitive Agreement
9:06am
424B3
awmn3hui
12 Nov 20
Prospectus supplement
6:08am
S-4/A
xhzhnf96bys4x8k t954
28 Oct 20
Registration of securities issued in business combination transactions (amended)
4:59pm
S-4
q5bd9
23 Sep 20
Registration of securities issued in business combination transactions
4:50pm
8-K
EX-2.1
gkpkjl7g w64mgp2
24 Aug 20
Yumanity Therapeutics and Proteostasis Therapeutics Announce
5:31pm
425
EX-2.1
rpb7fkmsbpluxu
24 Aug 20
Business combination disclosure
5:28pm